Insider Shareholders with Direct Ownership of Day One Biopharmaceuticals, Inc. (DAWN)
This section provides a comprehensive overview of the insiders with direct ownership of Day One Biopharmaceuticals, Inc. (DAWN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Day One Biopharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 12,929,322 | 0 | 12,929,322 $167 Million | 9 |
Oct 20, 2023
Added 0.85%
|
|
|
Canaan Xi L.P.
> 10% Shareholder |
7,489,776 | 3,771,344 | 6,964,301 $89.8 Million | 10 |
Sep 21, 2022
Reduced 17.72%
|
|
Atlas Venture Fund Xi, L.P.
> 10% Shareholder |
0 | 2,002,846 | 6,008,534 $77.5 Million | 3 |
Dec 12, 2022
Reduced 9.09%
|
|
Samuel C. Blackman
HEAD OF R&D |
49,988 | 1,404,253 | 1,034,015 $13.3 Million | 47 |
Dec 10, 2024
Reduced 2.82%
|
|
Atlas Venture Opportunity Fund I, L.P.
> 10% Shareholder |
0 | 198,280 | 793,116 $10.2 Million | 1 |
Jul 01, 2022
Reduced 20.0%
|
|
Atlas Venture Opportunity Fund Ii, L.P.
> 10% Shareholder |
766,667 | 0 | 766,667 $9.89 Million | 1 |
Jun 17, 2022
Added 50.0%
|
|
Charles N York Ii
COO, CFO AND SECRETARY |
61,000 | 161,891 | 240,133 $3.1 Million | 35 |
Nov 18, 2024
Reduced 1.07%
|
|
Jeremy Bender
CHIEF EXECUTIVE OFFICER |
127,492 | 733,753 | 108,377 $1.4 Million | 36 |
Nov 18, 2024
Reduced 8.87%
|
| 7,000 | 0 | 72,292 $932,566 | 1 |
Jun 01, 2021
Added 8.83%
|
|
| 0 | 10,000 | 40,485 $522,256 | 1 |
Jun 21, 2024
Reduced 19.81%
|
|
|
Adam Dubow
GENERAL COUNSEL |
47,196 | 18,175 | 32,162 $414,889 | 10 |
Nov 18, 2024
Reduced 8.96%
|
|
Daniel J. Becker
Director |
5,000 | 0 | 5,000 $64,500 | 1 |
Jun 01, 2021
Added 50.0%
|